Similar articles

• Fluorodeoxyglucose uptake predicts survival in a CT screening trial.

  Erasmus JJ. Erasmus JJ. J Thorac Oncol. 2009 Nov;4(11):1305-6. doi: 10.1097/JTO.0b013e3181bd2909. J Thorac Oncol. 2009. PMID: 19861902 No abstract available.
• Overestimation of the prognostic significance of SUV measurement by positron emission tomography for non-small-cell lung cancer.

  Atkins CD. Atkins CD. J Clin Oncol. 2005 Sep 20;23(27):6799-800; author reply 6800. doi: 10.1200/JCO.2005.01.8465. J Clin Oncol. 2005. PMID: 16170191 No abstract available.
• Use of anthropometric factors in 18F-FDG PET bone marrow SUVs.

  Thie JA. Thie JA. J Nucl Med. 2006 Nov;47(11):1901-2; author reply 1902. J Nucl Med. 2006. PMID: 17079825 No abstract available.
• Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project.

  Paesmans M, Berghmans T, Dusart M, Garcia C, Hossein-Foucher C, Lafitte JJ, Mascaux C, Meert AP, Roelandts M, Scherpereel A, Terrones Munoz V, Sculier JP; European Lung Cancer Working Party, and on behalf of the IASLC Lung Cancer Staging Project. Paesmans M, et al. J Thorac Oncol. 2010 May;5(5):612-9. doi: 10.1097/JTO.0b013e3181d0a4f5. J Thorac Oncol. 2010. PMID: 20234323
• Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: a brief review.

  Kased N, Erasmus JJ, Komaki R, Cox JD. Kased N, et al. J Thorac Oncol. 2008 May;3(5):534-8. doi: 10.1097/JTO.0b013e31816de265. J Thorac Oncol. 2008. PMID: 18449010 Review.